News

Stay Up to Date 
with the Latest
News.

The science
moves fast
and so do
the stories.

ADDF Financing

Alzheimer’s disease: The Alzheimer’s Drug Discovery Foundation (ADDF) invests $4.2M in GliaPharm to advance its lead program

New collaboration

UCB

New hire at GliaPharm SA

New CDO & CMO

Collaboration

Wyss center

Innosuisse support

GliaPharm receives support from Innosuisse for a project to develop specific cell therapy to treat neurological diseases in collaboration with Universities of Bern and Lausanne.

HEPIA collaboration

GliaPharm receives grant for collaboration with HEPIA to setup a new 3D culture method using brain organoids from mouse and human-derived cells.

European Congress of Neuropsychopharmacology

GliaPharm to present at the European Congress of Neuropsychopharmacology – Symposium on “Beyond the Neurocentric Paradigm: Targeting Astrocytes and Neuroglial Interactions in CNS Disorders”. September 13th 2020.

LifeSci Symposium

GliaPharm presented at the LifeSci Partners Summer Symposium on August 5th 2020

#FOXG1

GliaPharm to present at the virtual #FOXG1ScienceSymposium on August 17/18. Register here to tune in to hear from all the researchers, industry and more about the path to a cure for #FOXG1. #FOXG1SS2020

CHF 2 Million financing

GliaPharm completes a CHF 2 Million financing to advance its drug development program for an orphan neurological disease